Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 813 results for "daiichi sankyo company"

Daiichi Sankyo Company Launches Tender Offer for Shares in Amb...

On Friday October 10, U.S. Eastern Time, Daiichi Sankyo Company through its wholly-owned U.S. subsidiary, Charge Acquisition Corp., launched a tender offer to acquire the outstanding common stock of Ambit Biosciences Corp. for $15.00 per share plus ... Individual.com, 1 week ago
[x]  

3 images for "daiichi sankyo company"

Securities Technology Monitor, 3 days ago
I Stock Analyst, 2 weeks ago
Securities Technology Monitor, 2 weeks ago
Bio Spectrum Asia

Daiichi Sankyo submits sNDA for treatment of tuberculosis disorders in Japan

Daiichi Sankyo Company Limited, a Japanese pharmaceutical company, and its generic subsidiary, Daiichi Sankyo Espha Co., Ltd., have submitted a supplemental new drug application, or sNDA, for the synthetic broad-spectrum oral antibacterial agent, ...
 Individual.com2 weeks ago Daiichi Sankyo seeks approval for TB drug in Japan  Bio Spectrum Asia2 weeks ago Daiichi Sankyo Espha seeks Japanese nod for Cravit & levofloxacin tablets to treat pulmonary and other tuberculosis disorders  PharmaBiz2 weeks ago Sun Pharma banks on Daiichi Sankyo to enter Japan market: Reports  India Infoline2 months ago

Perosphere, Daiichi Sankyo Join Hands for Phase III Trials of PER977

Perosphere Inc. and Daiichi Sankyo Company, Limited have entered into a clinical trial agreement under which Daiichi Sankyo will support and co-sponsor a phase 1 clinical study testing the safety, tolerability and effectiveness of PER977 to reverse ...
 PharmaAsia2 weeks ago Perosphere enters third clinical trial collaboration agreement with Daiichi Sankyo  PharmaBiz2 weeks ago Perosphere and Daiichi Sankyo collaborate on Ph III study of PER977 with edoxaban  Pharma Letter2 weeks ago Perosphere and Daiichi Sankyo Enter into a Clinical Trial Collaboration Agreement for Phase 3 Studies of PER977 to Investigate Reversal of the Anticoagulant Activity of the Investigational Factor Xa-Inhibitor Edoxaban  Scottrade2 weeks ago
[x]  
HealthCareIT News

Center for Connected Health and Daiichi Sankyo, Inc. Sign Agreement to Co-Develop a Mobile App to Support Patients with Atrial Fibrillation

BOSTON , Oct. 22, 2014 --The Center for Connected Health today announced a co-development agreement with Daiichi Sankyo, Inc. to create a mobile app to serve as a coaching platform for patients with atrial fibrillation who have been prescribed oral ...
 ITbriefing1 day ago Center for Connected Health, Daiichi Sankyo ink mobile app agreement  Center Watch14 hours ago
[x]  

Daiichi Sankyo receives approval for anticoagulant drug in Japan

(MarketLine via COMTEX News Network) -- Daiichi Sankyo Company, Limited, a research-based pharmaceutical company, has received approval from the Ministry of Health, Labour and Welfare in Japan for LIXIANA for the prevention of ischemic stroke and ...
 PredictWallStreet3 weeks ago
Securities Technology Monitor

Ambit Biosciences Corp (NASDAQ:AMBI) Investor Alert: Lawsuit Filed to Halt Takeover by Daiichi Sankyo Company

A lawsuit was filed by investor in shares of Ambit Biosciences Corp (NASDAQ:AMBI) filed a lawsuit in effort to halt the proposed takeover of NASDAQ:AMBI stockholders should contact the Shareholders Foundation. San Diego, CA -- (ReleaseWire) -- ...
 Digital Journal1 week ago AMBIT BIOSCIENCES : NASDAQ:AMBI) Investor Alert: Lawsuit Filed to Halt Takeover by Daiichi Sankyo Company  4 Traders1 week ago
[x]  

SC TO-T - Daiichi Sankyo Company, LTD (0001340156) (Filed by)

Document Format Files Seq Description Document Type Size 1 SC TO-T d800431dsctot.htm SC TO-T 45788 2 EX-99.(A)(1)(I) d800431dex99a1i.htm EX-99.(A)(1)(I) 471966 3 EX-99.(A)(1)(II) d800431dex99a1ii.htm EX-99.(A)(1)(II) 177960 4 EX-99.(A)(1)(III) ...
 SEC Filings1 week ago
Rediff.com

Ranbaxy to pay $40M to settle Texas litigation

Daiichi Sankyo-controlled Indian drug major Ranbaxy Laboratories Ltd, which awaits a regulatory clearance to go ahead with a proposed merger with Sun Pharma, has decided to settled the litigation concerning its participation in the Texas Medicaid ...
 VC Circle1 week ago 40 years ago and now: How Ranbaxy moved out of family control  Rediff.com2 days ago 40 Years Ago... And now: Ranbaxy grew with liberal regimes, moving out of family control  Business Standard India2 days ago
Sify

Ranbaxy staff get pay-cut shield in Sun buyout

The agreement agreed to by Sun Pharmaceutical Industries for a buyout of Ranbaxy Laboratories from Daiichi Sankyo provides for a year's 'cooling period' during which the pay of Ranbaxy employees cannot be lowered, it is learnt. Ranbaxy is said to ...
 Sify4 days ago Ranbaxy Laboratories??? Staff Get Pay-Cut Shield In Sun Pharmaceutical Industries Ltd Buyout  BioSpace3 days ago Sun Pharma posts Q1 profit on strong US sales  The Financial Chronicle2 months ago
Securities Technology Monitor

EQUITY ALERT: Rosen Law Firm Announces Investigation of Ambit Biosciences Corporation Concerning its Proposed Sale to Daiichi Sankyo Company, Ltd.

Company Website: http://rosenlegal.com/cases-381.html NEW YORK -- (Business Wire) The Rosen Law Firm, P.A. announces that it is investigating the Board of Directors of Ambit Biosciences Corporation (NASDAQ:AMBI) for possible ...
 Stockwatch3 weeks ago Lifshitz & Miller Law Firm Announces Investigation of AcelRx Pharmaceuticals, Inc., Ambit Biosciences, Athlon..  ADVFN India2 weeks ago Athlon Energy : Lifshitz & Miller Law Firm : Announces Investigation of AcelRx Pharmaceuticals, Inc., Ambit Biosciences, Athlon Energy Inc., LipoScience, Inc., Simplicity Bancorp, Inc., and TIBCO Software Inc.  4 Traders2 weeks ago Ambit Biosciences : EQUITY ALERT: Rosen Law Firm Announces Investigation of Ambit Biosciences Corporation Concerning its Proposed Sale to Daiichi Sankyo Company, Ltd.  4 Traders3 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less